questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzofuranes
Benzofuranes : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzofuranes : Questions médicales les plus fréquentes",
"headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzofuranes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amiodarone",
"alternateName": "Amiodarone",
"url": "https://questionsmedicales.fr/mesh/D000638",
"about": {
"@type": "MedicalCondition",
"name": "Amiodarone",
"code": {
"@type": "MedicalCode",
"code": "D000638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dronédarone",
"alternateName": "Dronedarone",
"url": "https://questionsmedicales.fr/mesh/D000077764",
"about": {
"@type": "MedicalCondition",
"name": "Dronédarone",
"code": {
"@type": "MedicalCode",
"code": "D000077764",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzbromarone",
"alternateName": "Benzbromarone",
"url": "https://questionsmedicales.fr/mesh/D001553",
"about": {
"@type": "MedicalCondition",
"name": "Benzbromarone",
"code": {
"@type": "MedicalCode",
"code": "D001553",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cantharidine",
"alternateName": "Cantharidin",
"url": "https://questionsmedicales.fr/mesh/D002193",
"about": {
"@type": "MedicalCondition",
"name": "Cantharidine",
"code": {
"@type": "MedicalCode",
"code": "D002193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Citalopram",
"alternateName": "Citalopram",
"url": "https://questionsmedicales.fr/mesh/D015283",
"about": {
"@type": "MedicalCondition",
"name": "Citalopram",
"code": {
"@type": "MedicalCode",
"code": "D015283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.187"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Escitalopram",
"alternateName": "Escitalopram",
"url": "https://questionsmedicales.fr/mesh/D000089983",
"about": {
"@type": "MedicalCondition",
"name": "Escitalopram",
"code": {
"@type": "MedicalCode",
"code": "D000089983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fura-2",
"alternateName": "Fura-2",
"url": "https://questionsmedicales.fr/mesh/D016257",
"about": {
"@type": "MedicalCondition",
"name": "Fura-2",
"code": {
"@type": "MedicalCode",
"code": "D016257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Griséofulvine",
"alternateName": "Griseofulvin",
"url": "https://questionsmedicales.fr/mesh/D006118",
"about": {
"@type": "MedicalCondition",
"name": "Griséofulvine",
"code": {
"@type": "MedicalCode",
"code": "D006118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.275"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzofuranes",
"alternateName": "Benzofurans",
"code": {
"@type": "MedicalCode",
"code": "D001572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhi Xu",
"url": "https://questionsmedicales.fr/author/Zhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Wei Zhou",
"url": "https://questionsmedicales.fr/author/Wei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Ashraf A Abbas",
"url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Kamal M Dawood",
"url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Giovanni Luca Beretta",
"url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta",
"affiliation": {
"@type": "Organization",
"name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Trajectories and Correlates of Anger During the Perinatal Period.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/35987262",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jogn.2022.07.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Teachers' racialized anger: Implications for discipline disparities.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37507189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jsp.2023.05.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Problematic Anger in the Military: Focusing on the Forgotten Emotion.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36445637",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11920-022-01380-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Which drivers drive as they live and who are transformed while driving? Analysis of moderators in the relationship between general anger and driving anger.",
"datePublished": "2024-07-25",
"url": "https://questionsmedicales.fr/article/39251286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jsr.2024.07.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "The people behind the papers - Andy Yang and Stephane Angers.",
"datePublished": "2024-03-04",
"url": "https://questionsmedicales.fr/article/38436209",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.202789"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzofuranes",
"item": "https://questionsmedicales.fr/mesh/D001572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzofuranes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzofuranes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzofuranes",
"description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Anger&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzofuranes",
"description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Anger&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzofuranes",
"description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Anger&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzofuranes",
"description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Anger&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzofuranes",
"description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Anger&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzofuranes",
"description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Anger&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux benzofuranes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les benzofuranes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux benzofuranes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils visibles sur des tests standards ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des benzofuranes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les benzofuranes provoquent-ils des effets psychologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils le système respiratoire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose de benzofuranes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux benzofuranes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité sont recommandées en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle."
}
},
{
"@type": "Question",
"name": "Comment gérer les déchets contenant des benzofuranes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les benzofuranes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère."
}
},
{
"@type": "Question",
"name": "La décontamination est-elle nécessaire après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des benzofuranes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils affecter la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications liées aux benzofuranes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est recommandé pour détecter les complications précoces."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'exposition aux benzofuranes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils présents dans des produits courants ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux benzofuranes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils différemment les sexes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées."
}
}
]
}
]
}
To investigate trajectories of anger during pregnancy and the early postpartum period; to identify baseline psychosocial predictors of anger trajectory group membership; and to examine correlates of a...
Longitudinal descriptive design....
We recruited participants from a maternity clinic in Calgary, Alberta, Canada....
The sample included a convenience sample of 143 pregnant women who had basic fluency in English, were older than 17 years of age, and were less than 19 weeks gestation with a single fetus at the time ...
Participants completed online questionnaires at four time points: early, mid-, and late pregnancy and 2 months after birth. We used group-based semiparametric mixture modeling to estimate patterns of ...
We identified four distinct trajectories of anger during pregnancy through 2 months after birth: minimal-stable anger (55%), mild-stable anger (24%), moderate-stable anger (14%), and high-decreasing a...
Higher levels of anger were associated with worse mental health in pregnancy and after childbirth in our participants. Women should be made aware of anger as a possible mood disturbance by clinicians,...
The contribution of racial bias to teachers' racialized discipline practices is increasingly clear, but the processes by which these biases are activated are less well understood. This study examined ...
Problematic anger is common in veteran and military populations, yet understudied relative to other mental health difficulties. However, in recent years, more clinical and research attention has been ...
In longitudinal research, findings show that problematic anger changes over the life course of military members and veterans, and that deployment increases the likelihood of problematic levels of ange...
Trait driving anger is a widely studied personality variable in the field of road safety, due to its strong relationship with both risky behavior on the road and crash-related events. The Deffenbacher...
The current research aimed to analyze the relationship between trait general anger and each one of the situations provoking anger, as well as to search for personality variables that could moderate th...
The results showed significant moderation effects in the case of Hostile gestures, Discourtesy, Illegal driving, and Slow driving. Conditional processes of these moderations were analyzed. Lastly, pra...
Activation of the Wnt signalling pathway is vital in the anterior-posterior patterning during neural development. In a new study, Stephane Angers and colleagues leverage previously developed selective...
Comorbid with chronic pain are negative emotions, anger being particularly salient. To evaluate specific relationships between pain and anger, the present study deconstructed anger into five parameter...
The Anger Parameters Scale (APS) was used to rate five parameters of anger: frequency, duration, intensity, latency, and threshold. Also rated was the physical sensation of pain and the degree of dist...
Descriptive statistics revealed: APS total M=71.52, SD=16.68, Sensory pain M=6.27, SD=2.15, Affective pain M=5.76, SD=2.28. Sensory and affective pain were highly correlated, r=0.70. APS total was sig...
Scores for all variables were in the mid-range. As hypothesized, anger was more strongly correlated with distress/suffering of pain than with physical sensation of pain, though both pain components we...
Anger dyscontrol is a common issue after traumatic brain injury (TBI). With the growth of wearable physiological sensors, there is new potential to facilitate the rehabilitation of such anger in the c...
This study collected the TRIEP (Toronto Rehabilitation Institute Emotion-Physiology) dataset, which comprised of 32 individuals (10 TBI), exposed to a variety of elicitation material (film, pictures, ...
Characteristics of PPG are largely dominated by inter-subject (between individuals) differences first, then intra-subject (day-to-day) changes, before differentiation into emotion. Both TBI and non-TB...
This work highlights how there are contextual, non-stationary challenges to the emotion-physiology relationship that must be accounted for before emotion regulation technology can perform in real-worl...
This study assessed the association of anger, anxiety, and depression, and cognitive bias with pain and activity tolerance among patients with a musculoskeletal illness or injury expected to last more...
The role of emotions and cognition in entrepreneurship and strategic decision-making research has thus far been relatively neglected. In this research, we investigate how anger and hope may influence ...
Chronic pain increases the risk of substance use in people living with HIV (PLWH). Depression and anxiety have also been identified as risk factors for substance use among PLWH. Relatedly, other negat...